Northern Trust Corp cut its position in shares of Plexus Corp. (NASDAQ:PLXS – Free Report) by 0.5% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 330,433 shares of the technology company’s stock after selling 1,667 shares during the period. Northern Trust Corp owned about 1.22% of Plexus worth $42,338,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also modified their holdings of the company. Aquatic Capital Management LLC increased its position in shares of Plexus by 134.0% during the fourth quarter. Aquatic Capital Management LLC now owns 234 shares of the technology company’s stock valued at $37,000 after purchasing an additional 134 shares during the period. Versant Capital Management Inc grew its position in Plexus by 1,000.0% in the first quarter. Versant Capital Management Inc now owns 473 shares of the technology company’s stock valued at $61,000 after acquiring an additional 430 shares during the period. TD Private Client Wealth LLC grew its position in Plexus by 185.6% in the first quarter. TD Private Client Wealth LLC now owns 514 shares of the technology company’s stock valued at $66,000 after acquiring an additional 334 shares during the period. N.E.W. Advisory Services LLC bought a new stake in Plexus in the first quarter valued at $87,000. Finally, Blue Trust Inc. grew its position in Plexus by 49.2% in the first quarter. Blue Trust Inc. now owns 846 shares of the technology company’s stock valued at $108,000 after acquiring an additional 279 shares during the period. 94.45% of the stock is currently owned by institutional investors.
Plexus Price Performance
Plexus stock opened at $139.62 on Friday. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.74 and a current ratio of 1.58. The firm has a market cap of $3.77 billion, a P/E ratio of 23.79 and a beta of 0.80. The business’s fifty day moving average is $133.01 and its two-hundred day moving average is $130.05. Plexus Corp. has a 52 week low of $103.43 and a 52 week high of $172.89.
Insider Transactions at Plexus
In other news, CFO Patrick John Jermain sold 2,178 shares of the company’s stock in a transaction on Wednesday, August 6th. The stock was sold at an average price of $130.42, for a total transaction of $284,054.76. Following the transaction, the chief financial officer owned 23,459 shares of the company’s stock, valued at $3,059,522.78. This represents a 8.50% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, COO Oliver K. Mihm sold 2,102 shares of the company’s stock in a transaction on Friday, August 15th. The shares were sold at an average price of $130.43, for a total value of $274,163.86. Following the transaction, the chief operating officer directly owned 21,155 shares in the company, valued at $2,759,246.65. This trade represents a 9.04% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 8,856 shares of company stock worth $1,158,610. 1.76% of the stock is owned by insiders.
Analysts Set New Price Targets
A number of analysts have weighed in on PLXS shares. Needham & Company LLC lowered their price target on Plexus from $162.00 to $158.00 and set a “buy” rating on the stock in a research report on Thursday, July 24th. Wall Street Zen cut Plexus from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 16th. Benchmark reiterated a “buy” rating and issued a $160.00 price target on shares of Plexus in a research report on Wednesday, June 4th. Stifel Nicolaus set a $140.00 price target on Plexus in a research report on Thursday, July 24th. Finally, Sidoti upgraded Plexus from a “neutral” rating to a “buy” rating and upped their price target for the company from $135.00 to $150.00 in a research report on Friday, July 25th. Three investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $152.00.
Check Out Our Latest Report on Plexus
About Plexus
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Further Reading
- Five stocks we like better than Plexus
- How to Calculate Options Profits
- Snowflake’s Snowballing Business and Robust Stock Price Outlook
- Stock Splits, Do They Really Impact Investors?
- Chevron Stock Outlook: Dividend Growth Meets Inflation
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Best Buy Marketplace: Potential Growth Catalyst or Risky Gimmick?
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.